Prosorba Column for Rheumatoid Arthritis
Prosorba, an antibody-adsorbing column used with plasmapheresis, has been approved by the FDA for treatment of moderate-to-severe rheumatoid arthritis in patients refractory or intolerant to methotrexate and other disease-modifying anti-rheumatic drugs (DMARDs)....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Prosorba Column for Rheumatoid Arthritis
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1058
Article Code: 1058c
Date: July 30, 1999
Volume: 41
Pages: 67-70
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1058
Article Code: 1058c
Date: July 30, 1999
Volume: 41
Pages: 67-70
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)